Impact of Treatments on Survival in Heart Attack Patients
Author Information
Author(s): Vanasse Alain, Courteau Josiane, Niyonsenga Théophile
Primary Institution: Université de Sherbrooke
Hypothesis
How do revascularization and cardioprotective drug treatments impact survival in myocardial infarction patients receiving usual care?
Conclusion
CV survival is positively correlated with revascularization procedures and the number of cardioprotective drugs used.
Supporting Evidence
- The study included 5596 patients who survived the index period after a myocardial infarction.
- 603 patients died from cardiovascular disease within two years, highlighting the impact of treatment.
- Revascularization significantly improved cardiovascular survival rates compared to no revascularization.
Takeaway
Patients who receive heart surgery and take heart-saving medications tend to live longer after a heart attack.
Methodology
Population-based cohort study using secondary data from Quebec's hospital discharge register.
Potential Biases
Potential unrecognized biases due to the nature of the data sources.
Limitations
The study relies on administrative databases, which may not account for all clinical conditions.
Participant Demographics
Patients aged 65 and older, with a mix of genders and varying comorbidity indices.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website